Ad
related to: california institute for regenerative medicine (cirm)
Search results
Avid Bioservices Inc (CDMO) Adjusts Fiscal 2024 Revenue Guidance Amidst Second Quarter Challenges
GuruFocus.com via Yahoo Finance· 6 months agoAvid Bioservices Inc (NASDAQ:CDMO) reports a second-quarter revenue of $25.4 million, a decrease...
Oncternal Therapeutics, Inc. (ONCT) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoJoining me on the call this afternoon are our president and CEO, Dr. James Breitmeyer; and our CMO,...
Fate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoRevenue: Reported $1.7 million for the fourth quarter of 2023. Operating Expenses: GAAP operating expenses were $49.8 million for the fourth quarter. Net Loss: Recorded a net loss of $44.1 million ...
Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoAvid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript December 7, 2023 Operator:...
Q3 2023 Lineage Cell Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Brian M. Culley; CEO, President & Director; Lineage Cell Therapeutics, Inc. Gary S. Hogge; SVP of Clinical & Medical Affairs; Lineage Cell Therapeutics, Inc. Ioana C. Hone; Director ...
